The licensed mental health providers listed in this directory specialize in anxiety, depression, OCD, PTSD, and related disorders. All providers listed are professional members of ADAA who have chosen to be included in this database.
Learn More
For media inquiries, please contact Lise Bram, ADAA Deputy Executive Director: [email protected]
Q&A
2022 Press Announcements and News Updates + −
ADAA Announces New Early Career Board Member - Mbemba Jabbi, PhD - February 28, 2022
ADAA 2022 Holds Annual Conference in Denver - February 8, 2022
ADAA Announces Early Career Board Seat Opening
ADAA Announces New Board President - Charles B. Nemeroff, MD, PhD - January 4, 2022
ADAA Announces Several New Board Appointments for 2022 - January 1, 2022
No
#ADAA2022 -Denver - Press Highlights + −
-
Unexpected Effect of Muscle Relaxation on Grief Severity, Medscape.com, March 29, 2022
-
High-Intensity Exercise Helps Patients With Anxiety Quit Smoking, Medscape.com, March 28, 2022
-
Staggeringly High' Rates of Psychiatric Symptoms After COVID-19, Medsape.com, March 28, 2022
-
Mental health disability identity relies on multiple personal factors, Healio.com, March 25, 2022
-
Speaker: Leadership in times of crisis requires personal awareness, Healio.com, March 24, 2022
-
Multiple barriers exist for youth access to exposure and response prevention therapy, Healio.com,, March 24, 2022
-
Pop culture references inform, improve cognitive behavioral therapy, Healio.com, March 23, 2022
-
Engagement, participation and humor key components for successful ERP therapy, Healio.com, March 23, 2022
-
Executive Function Deficits a New Treatment Target for PTSD?, Medscape.com, March 22, 2022
-
Intranasal esketamine safe, effective with psychotropics to treat depression, Healio.com, March 22, 2022
-
App used in conjunction with therapy linked to reduction in depression, anxiety, Healio.com, March 21, 2022
-
Mental health of college students altered as COVID-19 pandemic continued, Healio.com, March 18, 2022
-
Understanding factors related to suicidality leads to better therapeutic interventions, Healio.com, March 18, 2022
-
Engagement key in cognitive behavioral therapy for patients with body dysmorphic disorder, Healio.com, March 17, 202
ADAA 2022 Holds Annual Conference in Denver - February 8, 2022
No
2021 Press Announcements and News Updates + −
ADAA Accepting BIPOC Membership Scholarship Program Applications - October 8, 2021
ADAA Announces Three Open Board Seats - September 9, 2021
Registration Now Open for ADAA 2022 Annual Conference - July 26, 2021 -
ADAA Depression and Anxiety Journal 2020 Impact Factor Released - July 21, 2021
ADAA's 2022 Denver Conference Submissions Portal is Now Open! - July 8, 2021
It's Official - ADAA's New Website Has Launched - March 17, 2021
No
#ADAA2021Virtual Conference Press Release and News Articles + −
-
Mental Health Awareness Month: COVID-19 psychiatric morbidity, CBD product and more, Healio.com, May 4, 2021
-
Depressive Symptoms Plus Inflammatory Diet Add Up to Higher Frailty Risk, MedScape, Courtney Millar, Charles B. Nemeroff, MD, PhD, March 30, 2021
-
VistaGen's Poster Presentation at the Anxiety and Depression Association of America's 2021 Annual Conference Differentiates PH94B's Mechanism of Action from Highly-Addictive Benzodiazepines, Wall Street Journal, March 22, 2021
-
VistaGen’s Poster Presentation at the Anxiety and Depression Association of America’s 2021 Annual Conference Differentiates PH94B’s Mechanism of Action from Highly-Addictive Benzodiazepines, BioSpace.com, March 22, 2021
-
VistaGen’s Poster Presentation at the Anxiety and Depression Association of America’s 2021 Annual Conference Differentiates PH94B’s Mechanism of Action from Highly-Addictive Benzodiazepines, StreetInsder.com, March 22, 2021
-
Pandemic-Related Stress Associated With PTSD Symptoms Months Later, Psychiatry and Behavioral Health Learning Network, Davie WM, Stenson AF, Reda M, March 22, 2021
-
SNRI 'Shows Promise' for Comorbid ADHD, PTSD, Medscape.com, Zhewu Wang, MD, and comments by ADAA President-Elect and Chief Medical Officer Charles Nemeroff, MD, PhD, March 22, 2021
-
Motivational interviewing intervention feasible, acceptable for youths at risk for suicide, Healio.com, Ewa Czyz, PhD, March 22, 2021
-
Increases in Emotion Dysregulation, Repetitive Negative Thinking Seen During Pandemic, Psychiatry and Behavioral Health Learning Network, Tellez-Monnery K, McDermott MJ, March 22, 2021
-
Emphasizing coping methods may help at-risk youth navigate COVID-19 pandemic, Healio.com, Alexandra H. Bettis, PhD, March 19, 2021
-
Childhood Maltreatment May Predict Better Response to IV Ketamine, PsychCongress, O’Brien B, Lijffijt M, Murphy N, et al, March 19, 2021
-
Clear Goal Setting, Allowing Failure Are Key in Supporting Childrens’ Virtual Learning, PsychCongress, Jennifer Lynch, PsyD and Jenny Yip, PsyD, ABPP, March 19, 2021
-
People with trauma exposure at increased risk for obsessive-compulsive symptoms, Healio.com, Rose Luehrs, MA, MS, March 18, 2021
-
CBD product may reduce severe anxiety and related symptoms, Healio.com, Staci Gruber, PhD, March 18, 2021
- ADAA 2021 Virtual Conference - Press ReleaseFebruary 1, 2021
No
Press Releases and New Announcements - 2020 + −
-
ADAA Welcome Krystal Lewis, PhD to the Board of Directors - January 1, 2020
-
ADAA Announces #ADAA2021Virtual Conference - September 22, 2020
ADAA 2020 Conference News - Medscape.com
-
The findings were scheduled to be presented this month at the Anxiety and Depression Association of America (ADAA) Conference 2020, along with publication in the Journal of Affective Disorders. However, the ADAA conference was cancelled in the wake of the coronavirus pandemic.
- 04/07/2020 Worry, Anxiety Tied to Increased Inflammation, (ADAA Member) Megan Elizabeth Renna, PhD
- 04/06/2020 Rapid Response to PTSD Therapy May Predict Long-term Improvement
- 04/03/2020 IV Esketamine, Ketamine Equally Effective for Resistant Depression
- 03/31/2020 Mindfulness Interventions Linked to Cognitive Benefit, (ADAA member) Nur Hani Zainal, MS
No
Press Releases and New Announcements - 2018- 2019 + −
-
ADAA Congratulates Scott Rauch, MD, Board Secretary, on his Election to the National Academy of Medicine, October 29, 2019
ADAA 2019 Conference News
-
Disturbed Sleeps Derails Therapy for Complicated Grief, Medscape Medical News, April 9, 2019
-
Ketamine a Panacea for Resistant Depression? Not So Fast, Experts Say,Medscape Medical News, April 4, 2019
-
Self-Help App Helps Reduce Depression, Anxiety Symptoms, Healio, April 3, 2019
-
Songwriting May Hit the Right Therapeutic Note in PTSD, Medscape Medical News, April 3, 2019
-
Immunosuppressant May Extend Ketamine's Antidepressant Effects, Medscape Medical News, April 2, 2019
-
Patients with Anxiety, Mood Disorders Lack Self-compassion, Healio, April 1, 2019
-
Ketamine Improves Suicidal Ideation in Veterans with PTSD, MDD, Healio, April 1, 2019
-
Combination Therapy for PTSD Provides No Added Benefit, Medscape Medical News, April 1, 2019
-
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder, VistaGen Therapeutics Press Release (research poster presented at #ADAA2019), April 1, 2019
-
#ADAA2019 Conference - Press Release - January 14, 2019
-
KidGuard Grant Awarded to ADAA - November 15, 2018
-
ADAA Statement on PTSD, Panic, and Sexual Assault - September 26, 2018
-
ADAA Statement on the Tragic Losses of Kate Spade and Anthony Bourdain - June 8, 2018
-
ADAA Welcomes Luana Marques, PhD as President-Elect - April 13, 2018
-
ADAA Has Been Nominated for the 2018 Change Maker Award! - March 9, 2018
-
A Message from the ADAA Board - January 10, 2018
-
ADAA Welcomes Beth Salcedo, MD as New Board President - January 3, 2018
-
Hope and Grace Fund Grant Awarded to ADAA - October 27, 2017
No
Organizational News + −
- ADAA Announces the Launch of a New Website and Logo - February 18, 2021
- ADAA Welcome Krystal Lewis, PhD to the Board of Directors - January 1, 2020
- ADAA Announces #ADAA2021Virtual Conference - September 22, 2020
- ADAA Congratulates Scott Rauch, MD, Board Secretary, on his Election to the National Academy of Medicine, October 29, 2019
- KidGuard Grant Awarded to ADAA - November 15, 2018
- ADAA Statement on PTSD, Panic, and Sexual Assault - September 26, 2018
- ADAA Statement on the Tragic Losses of Kate Spade and Anthony Bourdain - June 8, 2018
- ADAA Welcomes Luana Marques, PhD as President-Elect - April 13, 2018
- ADAA Has Been Nominated for the 2018 Change Maker Award! - March 9, 2018
- A Message from the ADAA Board - January 10, 2018
- ADAA Welcomes Beth Salcedo, MD as New Board President - January 3, 2018
- Hope and Grace Fund Grant Awarded to ADAA - October 27, 2017
No
ADAA 2020 Conference News - Medscape.com + −
The findings were scheduled to be presented this month at the Anxiety and Depression Association of America (ADAA) Conference 2020, along with publication in the Journal of Affective Disorders. However, the ADAA conference was cancelled in the wake of the coronavirus pandemic.
- 04/07/2020 Worry, Anxiety Tied to Increased Inflammation, (ADAA Member) Megan Elizabeth Renna, PhD
- 04/06/2020 Rapid Response to PTSD Therapy May Predict Long-term Improvement
- 04/03/2020 IV Esketamine, Ketamine Equally Effective for Resistant Depression
- 03/31/2020 Mindfulness Interventions Linked to Cognitive Benefit, (ADAA member) Nur Hani Zainal, MS
No
ADAA 2019 Conference News + −
Disturbed Sleeps Derails Therapy for Complicated Grief, Medscape Medical News, April 9, 2019
Ketamine a Panacea for Resistant Depression? Not So Fast, Experts Say Medscape Medical News, April 4, 2019
Self-Help App Helps Reduce Depression, Anxiety Symptoms, Healio, April 3, 2019
Songwriting May Hit the Right Therapeutic Note in PTSD, Medscape Medical News, April 3, 2019
Immunosuppressant May Extend Ketamine's Antidepressant Effects, Medscape Medical News, April 2, 2019
Patients with Anxiety, Mood Disorders Lack Self-compassion, Healio, April 1, 2019
Ketamine Improves Suicidal Ideation in Veterans with PTSD, MDD, Healio, April 1, 2019
Combination Therapy for PTSD Provides No Added Benefit, Medscape Medical News, April 1, 2019
Positive Pilot Phase 3 Data Position VistaGen’s PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder, VistaGen Therapeutics Press Release (research poster presented at #ADAA2019), April 1, 2019
#ADAA2019 Conference - Press Release - March 12, 2019
#ADAA2019 Conference - Press Release - January 14, 2019
No
#ffffff
